Skip to content

Silgan Holdings SLGN Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

Constellium logo
ConstelliumCSTM
$68M+11.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Segments

By segment

See full
Dispensing and Specialty Closures$48.49M+11.6%
Metal Containers$29.11M-6.8%
Custom Containers$4.85M-38.2%

Other financials

Income statement

See full
Revenue$1.6B+6.4%
Gross profit$265.8M-1.7%
Net income$63.0M-7.2%
EPS (diluted)$0.60-4.8%

Balance sheet

See full
Cash & equivalents$435.4M+23.3%
Total debt$5.7B-2.1%
Total equity$2.3B+11.4%
Total assets$9.3B+6.3%

Cash flow

See full
Operating cash flow-$799.6M-17.0%
CapEx$82.4M-0.6%
Free cash flow-$882.0M-15.1%

Valuation

See full
Market cap$4.4B-25.1%

Profitability

See full
Gross margin17.4%-0.2pp
Operating margin8.7%
Net margin4.3%-0.5pp
FCF margin4.7%-0.6pp

Returns & leverage

See full
Return on equity12.9%-1.6pp
Debt / equity2.4×-0.3×
Current ratio1.3×+0.1×